In vivo experiments showed that when oncogenic alterations of BRAFV600E, Cdkn2a−/−, and Pten−/− were induced in the melanocytes of immunocompetent mice, melanomas were generated in 100% of animals but fewer than 10% of the animals developed metastases. Here, CDKN2A is linked to melanoma.